Dietary and Lifestyle Factors Associated With Metabolic Syndrome in Urban Middle-Aged Women of Babol City, Mazandaran Province, Iran by Delavar, Mouloud Agajani
  
UNIVERSITI PUTRA MALAYSIA 
 
DIETARY AND LIFESTYLE FACTORS ASSOCIATED WITH 
METABOLIC SYNDROME IN URBAN MIDDLE-AGED WOMEN OF 
BABOL CITY, MAZANDARAN PROVINCE, IRAN 
 
 
 
 
 
 
 
 
 
 
 
MOULOUD AGAJANI DELAVAR 
 
FPSK(P) 2009 3 
DIETARY AND LIFESTYLE FACTORS 
ASSOCIATED WITH METABOLIC SYNDROME 
IN URBAN MIDDLE-AGED WOMEN OF BABOL 
CITY, MAZANDARAN PROVINCE, IRAN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MOULOUD AGAJANI DELAVAR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DOCTOR OF PHILOSOPHY 
UNIVERSITI PUTRA MALAYSIA 
 
 
2009 
 
 
DIETARY AND LIFESTYLE FACTORS ASSOCIATED WITH METABOLIC 
SYNDROME IN URBAN MIDDLE-AGED WOMEN OF BABOL CITY, 
MAZANDARAN PROVINCE, IRAN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
By 
 
MOULOUD AGAJANI DELAVAR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis Submitted to the School of Graduate Studies, Universiti Putra Malaysia, 
in Fulfilment of the Requirements for the Degree of Doctor of Philosophy 
 
August 2009 
 ii
Abstract of thesis presented to the Senate of University Putra Malaysia in fulfilment 
of the requirement for the degree of Doctor of Philosophy 
 
 
DIETARY AND LIFESTYLE FACTORS ASSOCIATED WITH METABOLIC 
SYNDROME IN URBAN MIDDLE AGED WOMEN OF BABOL CITY, 
MAZANDARAN PROVINCE, IRAN 
 
 
By 
MOULOUD AGAJANI DELAVAR 
August 2009 
 
Chairman:         Professor Dr. Lye Munn Sann   
Faculty:             Medicine and Health Sciences 
 
 
Metabolic syndrome is a cluster of interconnected cardiovascular risk factors.  
Existing data suggest that it has reached an alarming rate, and it is found more 
common in women than in men.  Obesity plays a central role in metabolic syndrome 
and it has become a common factor among Iranian women.  Accordingly, it is 
important to elucidate both lifestyle and dietary factors to the development of 
metabolic syndrome among middle-aged women so as to prevent and manage the 
syndrome in a much better way.  
 
The research design of the present thesis was a population-based cross-sectional 
study, and the criteria by the NCEP ATP III were used to classify subjects with 
metabolic syndrome.  Meanwhile, their physical activities were measured using the 
original International Physical Activity Questionnaires Long form.  Food frequency 
questionnaire (FFQ) was also used in assessing individual’s habitual intake.  A total 
of 984 individuals, aged 30-50 year old from fourteen active urban primary 
healthcare centres in Babol (Iran), were selected using a systematic random sampling 
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method and sampling proportionate to size.  Thus, lifestyle factors associated with 
metabolic syndrome were analyzed.   
 
Among the Babolian middle-aged women living in the urban area, the prevalence of 
metabolic syndrome was found to be 31.0 %.  Overweight and abdominal obesity 
were also observed, and these were found around 38.0 % and 76.6 %, respectively.  
Older age, higher waist circumference, higher systolic and diastolic blood pressure, 
low education level, housewife and occupation (technician) were found to be 
associated with the increased odds of metabolic syndrome.  Nevertheless, the 
adjusted odds ratio (OR) showed no significant associations between metabolic 
syndrome and smoking or the exposure to cigarette smoking.  The moderate intensity 
of the physical activities was positively associated with systolic blood pressure 
(rho=0.07, p=0.03), cholesterol (rho=0.07, p=0.04), and triglyceride (rho=0.67, 
p=0.04).  Meanwhile, vigorous physical activity was inversely correlated with waist 
circumference (rho=-0.07, p=0.04).  Their total physical activity was found to be 
positively correlated with triglyceride (rho=0.09, p= 0.01), but was inversely 
correlated with HDL-cholesterol (rho=-0.07, p=0.04).  The chi-square test did not 
reveal any statistically significant difference in the levels of the physical activities 
between these women, either with or without metabolic syndrome.  The mean total 
kilocalories consumed per day were 2965.  The study also suggests that a good 
dietary pattern which is rich in fruit, legumes, vegetables, cereals, and fish 
(component 1), as well as the high intakes of dairy products and eggs (component 4) 
decrease the likelihood of metabolic syndrome.  The adjusted OR for metabolic 
syndrome in women with low fat intake was significantly higher than in those 
women with high and moderate fat intake (OR=2.923; 95% CI=1.36, 6.28).  The risk 
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of metabolic syndrome for women in the first quartile category of calcium was found 
to be higher than those in the highest quartile (OR=13.200; 95% CI =7.94, 21.93), 
and in the lowest category of black tea was indicated as lower than those in the 
highest categories (OR=0.181; 95% CI =0.11, 0.31). 
 
The findings of the present study indicated that a high prevalence of obesity and 
metabolic syndrome was identified among the middle-aged women, making this 
syndrome one of the major public health problems in Babol.  Therefore, it is 
necessary to emphasize on the benefits of lifestyle modifications, including weight 
loss, and the intakes or consumption of more fruit, legumes, vegetables, cereals, fish, 
dairy products, and the increase in the intakes of food containing calcium in reducing 
the risk of metabolic syndrome. 
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Sindrom metabolik merupakan faktor yang membuktikan kewujudan penyakit 
kardiovascular.  Sindrom ini juga amat ketara di kalangan wanita berbanding lelaki. 
Obesiti memainkan peranan yang penting di dalam sindrom metabolik kerana ia 
merupakan faktor yang umumnya berlaku di kalangan wanita Iran.  Oleh itu, 
menerangkan bahawa pemakanan dan cara hidup seseorang adalah faktor yang 
menyumbang kepada perkembangan sindrom metabolik di kalangan wanita 
pertengahan tahun adalah sangat penting.  Pencegahan terhadap sindrom ini juga 
adalah lebih penting berbanding mengatasinya. 
 
Dalam thesis ini, kriteria yang dikenali sebagai NCEP ATP III telah digunakan untuk 
menjelaskan sindrom metabolik.  Aktiviti fizikal diukur menggunakan borang asal 
International Physical Activity Questionnaire Long.  Food frequency Questionnaire 
(FFQ) juga digunakan untuk mengukur tabiat pemakanan seseorang.  Untuk tujuan 
ini, sejumlah 984 individu yang berumur di antara 30-50 tahun dari 14 pusat 
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perkhidmatan kesihatan bandar di Babol (Iran) telah terlibat di dalam kajian yang 
menggunakan kaedah sampel serampang yang sistematik dan nisbah sampel yang 
dibuat mengikut saiz yang diperolehi.  Faktor cara hidup seseorang didapati 
mempunyai hubungan rapat dengan sindrom metabolik. 
 
Kadar sindrom metabolik di kalangan wanita pertengahan tahun di kawasan bandar 
Babol addalah 310 %.  Kajian juga mendapati bahawa berat badan yang melampau 
dan obesiti abdominal adalah 38.0 % dan 76.6 %.  Selain itu, golongan tua, ukuran 
keliling pinggang yang tinggi, tekanan darah systolik dan distolik yang tinggi, tahap 
pendidikan yang rendah, suri rumahtangga dan pekerjaan seperti juruteknik juga 
didapati berkait rapat dengan penigkatan peluang berlakunya sindrom metabolik.  
Pelarasan nishah berkaitan atau odds ratio (OR) menunjukkan sindrom metabolik 
tidak mempunyai hubungan yang ketara dengan tabiat merokok atau pendedahan 
seseorang terhadap asap rokok.  Intensisasi akiviti fizikal yang sederhana adalah 
berhubung rapat dengan tekanan darah systolik (rho=0.071, p=0.029), kolesterol 
(rh=0.064, p=0.037) dan triglyceride (rho=0.67, p=0.042).  Sebaliknya, aktiviti 
fizikal yang keterlaluan tidak berkaitan dengan ukuran pinggang (rho=-0.067, 
p=0.040).  Jumlah aktiviti fizikal adalah berkait rapat dengan triglyceride ((rho=0.09, 
p=0.006), tetapi tidak berkaitan dengan HDL-cholesterol (rho=0.69, p=0.036).  Ujian 
Chisquare menunjukkan tiada perbezaan yang mendadak didapati dalam statistik 
antara aktiviti fizikal wanita dengan adanya dan juga tanpa sindrom metabolik.  
Jumlah pengambilan kilocalories sehari ialah 2965.  Dapatan penyelidikan ini 
mengesyorkan bahawa pemakanan yang kaya dengan buah-buahan, kekacang, sayur-
sayuran, bijirin and ikan (komponen 1) dan juga pengambilan makanan tenusu dan 
telur (komponen 4) yang tinggi berkemungkinan dapat menurun peluang seseorang 
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untuk mendapat sindrom metabolik.  Pelarasan OR dalam sindrom metabolik di 
kalangan wanita yang mempunyai lemak rendah adalah lebih tinggi berbanding 
wanita yang mempunyai lemak tinggi dan sederhana (OR=2.923; 95% CI=1.36, 
6.28).  Sementara itu, risiko sindrom metabolik untuk wanita dalam kategori quartile 
tahap pertama dengan kalsium adalah lebih tinggi berbanding kategori quartile 
tertinggi (OR-13200; 95% CI=9.12, 21.43).  Dalam kategori quartile pertama, teh 
hitam adalah kategori yong paling rendah daripada mereka yang berada dalam 
kategori tertinggi (OR=0.181; 95% CI=0.105, 0.14). 
 
Kajian juga mengesahkan kewujudan obesiti yang tinggi dan sindrom metabolik 
dikesan di kalangan wanita pertengahan tahun, dan ini menjadikan sindrom ini 
sebagai masalah kesihatan yang utama di kalangan wanita di Babol.  Oleh itu, adalah 
penting untuk menitikberatkan perubahan cara hidup seseorang seperti 
mengurangkan berat badan, memakan lebih banyak buah-buahan, kekacang, sayur-
sayuran, bijirin, ikan, produk tenusu dan juga menambahkan pengambilan makanan 
yang mengandungi kalsium untuk mengurangkam risiko menghidapi sindrom 
metabolik. 
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CHAPTER 1 
 
INTRODUCTION 
1.1 Background 
 
Metabolic syndrome is a relatively new concept, but the clustering of individual 
cardiovascular risk factors has been well researched. For example, in the 1920s, 
investigators reported the event of hypertension, hyperglycemia, and hyperuricema in 
specific groups of individuals (Nilsson, 2000).  In the 1960s, hyperlipidemia and 
obesity were found to be associated with this cluster (Avogaro et al., 1967). In 1988, 
Gerald Reaven presented for the first time the concept of “syndrome X” for the 
clustering of cardiovascular risk factors such as hypertension, glucose intolerance, 
high triglycerides, and low HDL-cholesterol concentrations found in individuals who 
tend to develop cardiovascular diseases. Thus he suggested that the common 
characteristic of the syndrome was resistance to the action of insulin (Reaven, 
1988),and associating with other metabolic abnormalities including obesity, 
microalbuminuria, change in fibrinolysis, and coagulation (Björntorp, 1992; Yudkin, 
1999). The syndrome has also been called insulin resistance syndrome, 
cardiovascular syndrome, and recently is known as metabolic syndrome (Winkler et 
al., 2003). 
 
The World Health Organization (WHO) gave the first definition for the metabolic 
syndrome which is more complex and prescriptive. It defines that for individuals 
with normal glucose tolerance, evidence of insulin resistance is a required 
component for a diagnosis of metabolic syndrome (Alberti and Zimmet, 1998).  As a 
result, the definition given by the WHO tends to focus much more on patients with 
the potential for diabetes (impaired glucose tolerance, impaired fasting glucose, or 
insulin resistance) (Isomaa, et al., 2001). Later, the Adult Treatment Panel III (ATP 
III) criteria provide a practical tool to identify patients with increased risk for 
cardiovascular disease. Focus of ATP III is less on type 2 diabetes and more on 
cardiovascular disease, whereas the criteria given by WHO and the American 
Association of Clinical Endocrinologists (AACE) require further oral glucose testing, 
impaired fasting glucose and diabetes. Impaired glucose tolerance on oral glucose 
tolerance test indicates greater risk for diabetes than does the metabolic syndrome 
without raised high fasting glucose (Alberti and Zimmet, 1998; Executive Summary, 
2001; NCEP, 2002). 
 
It is generally agreed that there are two general approaches to treatment of the 
metabolic syndrome. Therapeutic lifestyle change make up first-line therapy for 
metabolic syndrome, with increased emphasis on weight reduction, regardless of the 
diagnostic criteria used (Ahmad et al., 1997; Dengel et al., 1998). The second 
approach, drug treatment, directly treats risk factors of the metabolic syndrome such 
as atherogenic dyslipidemia, hypertension, the prothrombotic state, and underlying 
insulin resistance (Rubins et al., 1999; Arntz et al., 2000).  
 
In a recent survey in the US, it was found that the prevalence of metabolic syndrome 
was around 25% in white Americans but higher in Mexican and black Americans 
(Ford, Giles and Dietz, 2002). According to the 2000 census data, around 47 million 
US adults have the metabolic syndrome. The National Cholesterol Education 
Programmed (NCEP) defined metabolic syndrome indirectly suggests that the risk 
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for coronary heart disease and diabetes has been poorly studied (NCEP, 2002). The 
efforts up until now undertaken in understanding this syndrome have confirmed the 
effect of metabolic imbalances in the development of critical chronic cardiovascular, 
neurological, immunologic, renal, and endocrine diseases. With pandemic increase in 
obesity rates, care for individual with the metabolic syndrome is very important in 
order to reduce the harmful effects caused by unhealthy diet, excessive eating, 
physical inactivity, smoking, and stress. Current clinical research studies have shown 
that changes in lifestyles can prevent or alter a biochemical imbalance that goes to 
clinical complications of the metabolic syndrome in elderly people. Weight loss can 
highly reduce the insulin resistance and also indirectly mitigate the metabolic 
syndrome risk factors. Improved long-term outcomes have been attained as a result 
of physicians' approval of eating and physical activity that could lead to several 
favorable parameters such as a healthier waist circumference and improved body 
mass index, lower blood pressure, improved HDL-cholesterol and triglyceride, and 
lower blood sugars along with a reduced C-reactive protein (Lara-Castro and Garvey, 
2004; National Blueprint for Increasing Physical Activity, 2006). While the 
clinicians await further research into behavioral science, adiposities, hormones, and 
the mechanistic connection between insulin resistance and other important factors 
that will help them identify new goal for therapy, they can do much by advancement 
of improved lifestyles for all individuals. 
 
1.2   Conceptual Framework for the Metabolic Syndrome 
 
There are three major reasons for cardiovascular disease as a disease of societal 
change leading to altered lifestyle as shown in figure 1.1. The first is a good one; we 
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